Title: Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.
Authors: Bergenstal, Richard M; Rosenstock, Julio; Arakaki, Richard F; Prince, Melvin J; Qu, Yongming; Sinha, Vikram P; Howey, Daniel C; Jacober, Scott J
Publication: Diabetes Care, 2013, Vol 36, Issue 7, pe107
ISSN: 0149-5992
Publication type: Academic Journal
DOI: 10.2337/dc13-0295

Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.

Bergenstal, Richard M; Rosenstock, Julio; Arakaki, Richard F; Prince, Melvin J; Qu, Yongming; Sinha, Vikram P; Howey, Daniel C; Jacober, Scott J